PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE BY MONOCLONAL ANTIBODY TO INTERLEUKIN-2 RECEPTOR
- 10 June 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 333 (8650), 1333-1334
- https://doi.org/10.1016/s0140-6736(89)92732-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH MONOCLONAL ANTIBODY TO IL-2 RECEPTORThe Lancet, 1988
- Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentationBlood, 1988
- IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIASThe Lancet, 1987
- PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2The Lancet, 1987
- Anti‐interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody‐receptor interactions in their antagonist effects on interleukin 2‐dependent T cell growthEuropean Journal of Immunology, 1986